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Background: The niche surgery of same-day bilateral total knee arthroplasty (sd-BTKA) continues to 
create debate amongst specialists in arthroplasty. To date, there is a significant lack of literature on obese 
patients undergoing sd-BTKA, and no study has evaluated outcomes of this procedure when compared to 
non-obese patients. Therefore, this study will perform a retrospective analysis to compare (I) incidence, (II) 
demographics, and (III) complications of sd-BTKA in non-obese, obese, and morbidly obese patients in the 
United States from 2009 to 2016.
Methods: The National Inpatient Sample (NIS) database was queried for all individuals that underwent 
sd-BTKA from 2009 to 2016. This returned 184,844 non-obese patients, 39,901 obese patients, and 20,394 
morbidly obese patients. Analyzed variables included mean age, mean length of stay (LOS), race, payer, 
age-adjusted Charlson Comorbidity Index score, discharge disposition, hospital charges, hospital costs, and 
complications. Chi-square analyses and analyses of variance were utilized to assess categorical and continuous 
variables, respectively.
Results: Non-obese patients most commonly underwent sd-BTKA over the course of the study. As weight 
status increased, mean age decreased and the proportion of females, LOS, hospital charges and costs, and 
proportion of discharges to skilled nursing facilities increased. Regression analysis demonstrated obese and 
morbidly obese cohorts were at an overall increased odds for experiencing complications. Specifically, obese 
patients were at increased risk for pulmonary emboli, periprosthetic joint infections, and respiratory failures, 
while morbidly obese patients are at increased risk for pulmonary emboli, respiratory failures, and urinary 
tract infections. 
Conclusions: Surgeons should thoroughly evaluate the risks and benefits of performing sd-BTKA on 
obese and morbidly obese patients, as both confer higher overall complication rates and increased length 
of stay. More research is necessary to characterize the cost analysis of this procedure, as health care models 
continue to transition to more cost-effective procedures.
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Introduction
Obesity has a negative impact on the body in a multitude 
of ways, including a six-fold increase in risk for knee 
osteoarthritis (1). As such, many patients with increased 
body mass indices (BMI) will present to providers with 
bilateral disease, with some necessitating total knee 
arthroplasties (TKA) (2). To avoid the morbidity of multiple 
operations, same-day bilateral total knee arthroplasty 
(sd-BTKA) may be an option for these patients, as some 
find appeal in a single surgery and hospitalization (3,4). 
Moreover, physicians may acquiesce to the procedure as 
investigations report decreased cumulative hospital stays and 
rehabilitation time (5-10). Despite the purported benefits 
of this procedure, studies have revealed increased risk for 
negative outcomes with the bilateral operation (9-13). 
As a consequence of the conflicting body of literature, the 
utility of sd-BTKA continues to generate debate amongst 
arthroplasty surgeons (14-16). 
Over time, the debate regarding sd-BTKA intensified 
to a level that warranted consensus recommendations 
in 2013 (4). Among several proposals, the presence of 
certain comorbidities, such as morbid obesity, were felt 
to warrant exclusion of individuals from consideration 
for the operation. This notion is predicated off studies 
identifying higher BMI patients as having an increased risk 
for complications when undergoing unilateral TKA (17-23), 
though several studies have demonstrated a lack of 
association between poor outcomes and high BMI (24-28). 
Ultimately, whether high BMI patients should be subjected 
to the cumulative risk of two unilateral TKAs or the single 
operation of sd-BTKA remains inconclusive, as no studies 
have investigated the prospect.
To date, there is a shortage of studies that have quantified 
the role of high BMI in patients undergoing sd-BTKA. 
Specifically, no study has evaluated the effect elevated BMI 
has on the outcomes of this procedure when compared to 
non-obese patients. Therefore, this study will compare (I) 
incidence, (II) demographics, and (III) outcomes of non-
obese, obese, and morbidly obese sd-TKA patients in the 
United States from 2009 to 2016. We present the following 




The National Inpatient Sample (NIS) database was queried 
for all individuals who underwent sd-BTKA from 2009 
to 2016. The NIS is a large, publicly available database 
gathered by the Agency for Healthcare Research and 
Quality (AHRQ) for the Healthcare Cost and Utilization 
Project (HCUP), which was created with the goal of 
improving health care delivery. The unweighted NIS 
database contains seven million hospital stays each year. 
When weighted, it represents approximately 35 million 
hospitalizations nationally (29). 
Patient selection
Using International Classification of Diseases, Ninth and 
Tenth Editions (ICD-9 and -10) procedural codes (ICD-9: 
‘81.54’; ICD-10: ‘0SRC069’, ‘0SRC06A’, ‘0SRC06Z’, 
‘0SRC0J9’, ‘0SRC0JA’, ‘0SRC0JZ’, ‘0SRC0KZ’, ‘0SRD069’, 
‘0SRD06A’ ,  ‘0SRD06Z’ ,  ‘0SRD0J9’ ,  ‘0SRD0JA’ , 
‘0SRD0JZ’, ‘0SRD0KZ’), an initial query was made to the 
NIS for those undergoing sd-BTKA. This was achieved by 
tallying patients who presented more than one TKA code 
(n=245,139). We then stratified patients into non-obese, 
obese (BMI >30 kg/m2; ICD-9: ‘278.00’, ‘278.03’; ICD-10: 
‘E66.09’, ‘E66.1’, ‘E66.8’, ‘E66.9’) and morbidly obese (BMI 
>40 kg/m2; ICD-9: ‘278.01’; ICD-10: ‘E66.01’, ‘E66.2’) 
cohorts utilizing their respective diagnosis codes. As this 
study was retrospective and utilized a deidentified database, 
it was deemed exempt from Institutional Review Board 
approval.
Variables
Patient variables included mean age, mean length of stay 
(LOS), sex, race, primary payer, age-adjusted Charlson 
Comorbidity Index (ACCI) score, and discharge disposition. 
Length of stay was defined as the stay from admission 
until discharge. Race was categorized into Caucasian, 
African American, Hispanic, Asian, Native American, and 
other. Primary payer included Medicare, Medicaid, private 
insurance, self-pay, no charge, and others. The ACCI is 
a prognostic tool employed to estimate 10-year mortality 
based on 19 comorbid conditions and is categorized in 
accordance with the number of present comorbidities, 
namely 0, 1, 2, or 3+ (30). Discharge disposition was 
categorized into routine, short-term hospital, skilled 
nursing facility, home with home health care, against 
medical advice, and deceased.
The analyzed outcomes included charges, costs, and 
complications. Charges represented the monetary amount 
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the hospital billed to the payer, while costs represented 
the monetary amount the hospital facility incurred for the 
inpatient stay. The charges associated with hospitals are 
an element recorded within the NIS database; although 
costs are not. In order to obtain costs, the yearly “Cost-to-
Charge Ratio” supplemental files provided by HCUP were 
utilized (29). All costs and charges were adjusted using 
the January 1, 2019 consumer price index. Complications 
included myocardial infarctions (MI), cardiac arrests, 
pulmonary emboli (PE), deep vein thromboses (DVT), 
cerebrovascular complications, sepsis, periprosthetic 
joint infections (PJI), hematomas/seromas, mechanical 
complicat ions,  respiratory fa i lures ,  pneumoniae, 
urinary tract infections (UTI), and blood transfusions. 
Cerebrovascular complications consisted of thromboses, 
emboli, or occlusions with or without cerebral infarction 
and/or hemorrhage. Mechanical complications represented 
intraoperative or perioperative fractures, mechanical 
breakdown, loosening, or dislocation of implants.
Statistical analysis
Chi-square analyses were used to analyze race, ACCI, 
primary payer, median household income, discharge 
destination, and complications. Student’s t-tests were 
performed to compare age, LOS, costs, and charges. Odds 
ratios for complications were determined by employing 
multinomial regression analyses. To reduce the chance of 
committing type I (alpha) error and more precisely identify 
statistical significance, post-hoc Bonferroni corrections were 
utilized. All analyses were conducted using the Statistical 
Package for the Social Sciences (SPSS®; IBM Corporation; 
Armonk, New York) version 25. A P value of 0.05 was 
considered the threshold for significance for all variables. 
Results
Incidence
Non-obese patients [n=184,844 (75.4%)] comprised the 
highest percentage of sd-BTKA procedures over the 
course of the study, which was followed by obese [n=39,901 
(16.3%)] and then morbidly obese [n=20,397 (8.3%)] 
patients (Table 1). 
Patient demographics
Age decreased, mean LOS increased, and proportion 
of females increased as BMI increased (P<0.001 for all). 
Caucasians were the most common race undergoing sd-
BTKA, although the proportion of African Americans 
increased as BMI increased (P<0.001). The number of 
individuals with an ACCI of 3+ decreased as obesity status 
increased, while those with ACCI statuses of 1 and 2 
increased as BMI increased (P<0.001). The most common 
payer was private insurance, which increased in proportion 
as BMI increased (P<0.001). Median household income 
quartiles 3 and 4 significantly decreased among morbidly 
obese individuals (P<0.001). Proportion of discharges 
to skilled nursing facilities increased as BMI increased 
(P<0.001).
Outcomes
Hospital costs and charges increased as BMI increased 
(P<0.001 for both) (Table 2). In comparison with the non-
obese patients, obese patients demonstrated significantly 
lower proportions of MIs (P=0.028), pneumoniae (P<0.001), 
and blood transfusions (P<0.001), while demonstrating 
significantly higher proportions of PE (P<0.001), respiratory 
failures (P<0.001), and PJIs (P=0.028) (Figure 1). For 
morbidly obese patients, significantly lower proportions 
were observed in DVTs (P=0.022), cerebrovascular 
complications (P=0.002), and blood transfusions (P<0.001), 
while significantly higher proportions were observed 
regarding PE (P<0.001), sepsis (P<0.001), respiratory 
failures (P<0.001), and UTIs (P<0.001). Only morbidly 
obese patients demonstrated a significantly increased overall 
complication rate compared to non-obese patients (P<0.001).
Multinomial regression analysis
When compared to non-obese patients, obese patients had 
a significantly reduced risk for MIs [odds ratio (OR): 0.659], 
cerebrovascular complications (OR: 0.685), pneumoniae 
(OR: 0.470), and blood transfusions (OR: 0.873) (P<0.003 
for all) (Figure 2; Table 3). Conversely, obese patients were 
at increased risk for PE (OR: 1.892), PJIs (OR: 1.471), and 
respiratory failures (OR: 1.375) (P<0.011 for all). Obese 
patients also demonstrated a slight, yet significant, overall 
increase in complication risk (OR: 1.107) when compared 
to non-obese patients (P<0.001).
When morbidly obese patients were compared to non-
obese patients, they had a significantly reduced risk for 
cerebrovascular complications (OR: 0.357), pneumoniae (OR: 
0.704), and blood transfusions (OR: 0.811) (P<0.006 for all). 
Remily et al. Obesity and sd-BTKA
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Table 1 Comparison of patient demographics between non-obese, obese, and morbidly obese patients that underwent same-day bilateral total 
knee arthroplasty from 2009 to 2016
Parameter (%) Non-obese Obese Morbidly obese P value
Incidence 184,844 (75.4) 39,901 (16.3) 20,394 (8.3)
Mean age (SD) 64.5 (9.3)‡ 62.2 (8.3)‡ 60.0 (8.1)‡ <0.001
Mean LOS (SD) 3.6 (2.0)‡ 3.7 (2.1)‡ 4.0 (2.6)‡ <0.001
Sex 0.001
Male 85,002 (46.0)‡ 15,667 (39.3)‡ 6,337 (31.1)‡
Female 99,722 (54.0)‡ 24,227 (60.7)‡ 14,057 (68.7)‡
Race <0.001
Caucasian 146,896 (87.4)‡ 30,046 (83.8)‡ 15,031 (81.4)‡
African American 9,423 (5.6)‡ 3,150 (8.8)‡ 2,043 (11.1)‡
Hispanic 4,710 (2.8) 1,382 (3.9)† 688 (3.7)†
Asian 2,536 (1.5)‡ 285 (0.8)‡ 93 (0.5)‡
Native American 500 (0.3) 144 (0.4)† 80 (0.4)†
Other 3,983 (2.4) 841 (2.3) 529 (2.9)†
Age-Adjusted Charlson Comorbidity Index Score <0.001
0 695 (0.4) 114 (0.3)† 64 (0.3)
1 7,653 (4.1)‡ 2,060 (5.2)‡ 1,469 (7.2)‡
2 39,112 (21.2) 9,500 (23.8)† 5,014 (24.6)†
3+ 137,383 (74.3)‡ 28,226 (70.7)‡ 13,846 (67.9)‡
Primary payer <0.001
Medicare 85,759 (46.6)‡ 15,123 (38.0)‡ 6,484 (31.9)‡
Medicaid 4,066 (2.2)‡ 1,010 (2.5)‡ 797 (3.9)‡
Private insurance 88,988 (48.3)‡ 22,431 (56.4)‡ 12,387 (61.0)‡
Self-pay 956 (0.5) 171 (0.4) 135 (0.7)†
No charge 99 (0.1) 29 (0.1) xxx†
Other 4,358 (2.4) 1,033 (2.6)† 507 (2.5)
Median household income <0.001
Quartile 1 37,458 (20.6) 8,100 (20.6) 5,085 (25.3)†
Quartile 2 47,137 (26.0) 10,305 (26.2) 5,538 (27.5)†
Quartile 3 48,282 (26.6) 11,181 (28.4)† 5,209 (25.9)
Quartile 4 48,625 (26.8)‡ 9,751 (24.8)‡ 4,280 (21.3)‡
Disposition <0.001
Routine 31,251 (16.9)‡ 6,119 (15.4)‡ 2,576 (12.7)‡
Short-term hospital 3,847 (2.1) 674 (1.7)† 320 (1.6)†
Skilled nursing facility 109,421 (59.2)‡ 24,981 (62.7)‡ 14,161 (69.5)‡
Table 1 (continued)
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Table 1 (continued)
Parameter (%) Non-obese Obese Morbidly obese P value
Home health care 39,989 (21.6)‡ 8,014 (20.1)‡ 3,284 (16.1)‡
Against medical advice 15 (0.0) xxx xxx
Deceased 201 (0.1) 25 (0.1) 20 (0.1)
xxx, number concealed in accordance with the Healthcare Cost and Utilization Project Data Use Agreement; †, a statistically significant 
difference compared to only the non-obese cohort; ‡, a statistically significant difference compared to other cohorts. SD, standard 
deviation; LOS, length of stay.
Table 2 Comparison of outcomes between non-obese, obese, and morbidly obese patients that underwent same-day bilateral total knee 
arthroplasty from 2009 to 2016
Parameter Non-obese Obese Morbidly obese P value
Hospital charges (SD) $86,588.40 ($51,106.39)‡ $88,025.10 ($46,906.11)‡ $89,961.58 ($51,922.47)‡ <0.001
Hospital cost (SD) $25,757.29 ($11,837.76) $25,767.99 ($11,080.72) $26,561.95 ($12,530.51)‡ <0.001
Complications, n (%)
Myocardial Infarctions 473 (0.3) 73 (0.2)† 49 (0.2) 0.028
Cardiac arrests 142 (0.1) 30 (0.1) 20 (0.1) 0.571
Pulmonary emboli 1,177 (0.6)‡ 423 (1.1)‡ 167 (0.8)‡ <0.001
Deep vein thromboses 800 (0.4) 152 (0.4) 64 (0.3)† 0.022
Cerebrovascular complications 480 (0.3) 83 (0.2) 29 (0.1)† 0.002
Sepsis 292 (0.2) 79 (0.2) 57 (0.3)† <0.001
Periprosthetic joint infections 222 (0.1) 69 (0.2)† 25 (0.1) 0.028
Hematomas/seromas 1,154 (0.6) 233 (0.6) 125 (0.6) 0.637
Mechanical complications 178 (0.1) 45 (0.1) 25 (0.1) 0.388
Respiratory failures 913 (0.5)‡ 279 (0.7)‡ 263 (1.3)‡ <0.001
Pneumoniae 894 (0.5) 114 (0.3)† 89 (0.4) <0.001
Urinary tract infections 3,184 (1.7) 626 (1.6) 547 (2.7)‡ <0.001
Blood transfusions 48,242 (26.1)‡ 9,543 (23.9)‡ 4,664 (22.9)‡ <0.001
Overall complication ratesα 8,398 (4.5) 1,899 (4.8) 1,236 (6.1)‡ <0.001
α, this variable does not include blood transfusions; †, a statistically significant difference compared to only the non-obese cohort; ‡, a 
statistically significant difference compared to other cohorts.
However, morbidly obese patients were at increased risk for 
PE (OR: 1.267), respiratory failures (OR: 2.217), and UTIs 
(OR: 1.464) (P<0.011 for all). Moreover, morbidly obese 
patients had a significantly increased overall complication risk 
(OR: 1.302) when compared to non-obese patients (P<0.001).
Discussion
Morbidity and mortality are the largest concerns 
surrounding sd-BTKA, and conflicting studies have 
generated debate regarding the appropriateness of this 
procedure. The present study utilized the NIS database to 
examine and identify outcomes of sd-BTKA patients with 
varying BMI levels, in an effort to characterize the degree 
of risk higher BMI patients sustain when undergoing 
this procedure, as no studies have done so previously. 
Predictably, LOS, hospital costs and charges, and overall 
inpatient complication rates increased as BMI increased. 
Remily et al. Obesity and sd-BTKA
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Figure 1 The proportion of complications experienced by non-obese, obese, and morbidly obese individuals undergoing same-day bilateral 
total knee arthroplasty. ∆, blood transfusions were not included in the overall complication rate; *, a statistically significant difference 
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Specifically, obese individuals demonstrated increased risk 
for PE, PJI, and respiratory failures, while morbidly obese 
individuals demonstrated increased risk for PE, sepsis, 
respiratory failures, and UTIs. Similar to unilateral TKA, 
the presence of obesity or morbid obesity appears to confer 
a higher level of overall risk for complications in patients 
undergoing sd-BTKA.
This study does possess limitations. As the present study 
was performed retrospectively, the authors were confined 
to the data presented within the NIS database. Second, the 
transition period from ICD-9 to ICD-10 medical coding 
systems occurred during our study. The new coding system 
may have caused providers to miscode sd-BTKAs, producing 
inconsistencies in our obtained incidence numbers. 
However, any data entry errors that occurred were likely 
diminished due to the considerable sizes of our analyzed 
Annals of Translational Medicine, Vol 8, No 15 August 2020 Page 7 of 12
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Figure 2 The degree of risk for complications obese and morbidly obese individuals sustain when undergoing same-day bilateral total knee 
arthroplasty. The non-obese cohort served as the reference when evaluating odds ratios.
cohorts. Moreover, querying the NIS in the method we 
chose did not delineate between simultaneous or sequential 
BTKA, which is why we opted for the term ‘same-day’. 
Nonetheless, both procedures are performed under the 
same anesthetic and may incur similar perioperative risk, 
as several studies have compared both approaches to staged 
BTKA or unilateral TKA (31-34). Third, the NIS database 
only captures the inpatient stay. Therefore, we were unable 
to measure readmissions and post-discharge complications. 
Although, this study provides a thorough analysis regarding 
the morbidity and mortality of patients with varying BMI 
statuses throughout the inpatient stay, which is arguably 
when the patient is subjected to the highest amount of risk. 
Although limitations exist in this study, the breadth of our 
analysis is comprehensive and provides valuable information 
pertaining to the role of BMI in the highly debated 
procedure of sd-BTKA.
In the present study, a significant difference was observed 
between BMI and hospital LOS. As BMI increased, the 
LOS also increased, with non-obese individuals staying an 
average of 3.6 days and morbidly obese individuals staying 
4.0 days. An increased LOS can have large implications on 
the postoperative outcomes TKA patients. Otero et al. (35) 
examined the association between LOS and complications 
in TKA patients from 2011 to 2013, finding patients staying 
four or more days experienced complication rates that were 
three times higher than those staying 3 days (3.41% vs. 
11.15%). Moreover, the cohort staying 4 days or longer 
had a higher average American Society of Anesthesiologists 
(ASA) scores, were older, and more likely to be female. 
Although LOS in itself was likely not the sole reason 
patients experienced higher complication rates, it appears to 
Remily et al. Obesity and sd-BTKA
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Table 3 Multiple regression of complication rates between non-obese, obese, and morbidly obese patients that underwent same-day bilateral total 
knee arthroplasty from 2009 to 2016
Parameter Adjusted odds ratio 95% confidence interval P value
Myocardial infarctions
Non-obese (ref.)
Obese 0.659 0.507–0.858 0.002
Morbidly obese 0.751 0.541–1.041 0.085
Cardiac arrests
Non-obese (ref.)
Obese 0.928 0.620–1.391 0.719
Morbidly obese 0.790 0.469–1.330 0.375
Pulmonary Emboli
Non-obese (ref.)
Obese 1.892 1.676–2.137 <0.001
Morbidly obese 1.267 1.059–1.517 0.010
Deep vein thromboses
Non-obese (ref.)
Obese 0.851 0.707–1.024 0.087
Morbidly obese 0.608 0.452–0.818 0.001
Cerebrovascular complications
Non-obese (ref.)
Obese 0.685 0.539–0.870 0.002
Morbidly obese 0.357 0.243–0.527 <0.001
Sepsis
Non-obese (ref.)
Obese 1.180 0.889–1.566 0.251
Morbidly obese 1.177 0.850–1.631 0.327
Periprosthetic joint infections
Non-obese (ref.)
Obese 1.471 1.102–1.965 0.009
Morbidly obese 0.837 0.520–1.349 0.466
Hematomas/seromas
Non-obese (ref.)
Obese 0.993 0.854–1.154 0.924
Morbidly obese 1.105 0.911–1.341 0.309
Table 3 (continued)
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Table 3 (continued)
Parameter Adjusted odds ratio 95% confidence interval P value
Mechanical complications
Non-obese (ref.)
Obese 1.384 0.988–1.938 0.059
Morbidly obese 1.373 0.881–2.138 0.161
Respiratory failures
Non-obese (ref.)
Obese 1.375 1.188–1.592 <0.001
Morbidly obese 2.217 1.890–2.601 <0.001
Pneumoniae
Non-obese (ref.)
Obese 0.470 0.376–0.587 <0.001
Morbidly obese 0.704 0.551–0.899 0.005
Urinary tract infections
Non-obese (ref.)
Obese 0.938 0.857–1.027 0.167
Morbidly obese 1.464 1.323–1.620 <0.001
Blood transfusions
Non-obese (ref.)
Obese 0.873 0.849–0.897 <0.001
Morbidly obese 0.811 0.781–0.842 <0.001
Overall complications§
Non-obese (ref.)
Obese 1.107 1.049–1.169 <0.001
Morbidly obese 1.302 1.217–1.393 <0.001
§, this variable does not include blood transfusions.
be an important factor that should be reduced, though this 
may not be readily possible when performing sd-BTKA. 
Thus, selecting patients with favorable characteristics, 
namely lower ASA or younger age, may be the next best 
option to optimize postoperative courses. Davidson et al. (36) 
did just that and assessed outcomes in sd-BTKA patients 
who were selected via their institutionally developed 
appropriateness of care criteria (AOCC) versus those who 
were not. Patients were considered ‘ideal’ candidates by 
the AOCC if they were younger than 70, did not have 
cardiac disease, diabetes, or lower extremity deformities, 
and were non-obese. With the AOCC stratification tool, 
the ideal cohort was younger (61 vs. 65 years), had fewer 
comorbidities, required a shorter LOS (3.6 vs. 3.9 days), 
and were discharged home more frequently (26% vs. 13%). 
While this study used obesity as an exclusion criterion, 
providers may observe good outcomes in higher BMI 
patients if they appropriately satisfy other criteria. Obese 
and morbidly obese individuals who underwent sd-BTKA 
in the present study appeared to be ‘healthier’ despite the 
presence of obesity, as evidenced by the reduced average 
ACCI and age. Performing sd-BTKA on high BMI 
individuals is possible, and risk stratifying patients in a 
manner similar to the AOCC may increase the likelihood of 
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achieving favorable outcomes.
Both obese and morbidly obese cohorts demonstrated 
increased odds for experiencing complications, but 
morbidly obese patients demonstrated a statistically 
significant increase in overall complications. Unfortunately, 
only a select few have examined the role of obesity in sd-
BTKA. In a retrospective study performed by Taylor 
et al. (37), the authors compared 1-year morbidity and 
mortality rates in obese patients undergoing either sd-
BTKA (n=151) or unilateral TKA (n=148), concluding 
both major (MI, PE, cerebrovascular accident, etc.) and 
minor (UTI, superficial infection, ileus, etc.) complication 
rates in sd-BTKA to be similar to unilateral TKA. Thus, 
obese individuals undergoing the procedure of sd-BTKA 
may not be at increased risk compared to their unilateral 
TKA counterparts. Madsen et al. (3) investigated morbidly 
obese patients receiving sd-BTKA by performing a ten-year 
analysis of outcomes in non-obese (n=79) and morbidly 
obese patients (n=42).  The authors found similar 
complication rates between the two cohorts, with both 
experiencing four major complication events. The obese 
cohort experienced one PE, one extensor mechanism 
disruption, and two DVTs, while the morbidly obese 
cohort experienced one MI, one extensor mechanism 
disruption, and two DVTs. Although the authors provided 
a long-term analysis of sd-BTKA patients, the number 
of patients examined in each cohort was insufficient to 
make appropriate conclusions regarding the procedure. 
Predicated off the limited literature assessing BMI status 
and sd-BTKA, the benefit of this procedure remains 
inconclusive, though it may be appropriate for higher BMI 
individuals with desirable comorbidity profiles. Moreover, 
opting to perform sd-BTKA may benefit select higher BMI 
patients considering staged BTKA. In a study performed 
by Grace et al. (38), the authors examined the risk for 
recurrent complications (MI and other cardiac-related 
complications, ischemic stroke, respiratory complications, 
digestive complications, urinary complications, and 
hematomas) in staged BTKA patients after they experienced 
a complication following their initial unilateral TKA. The 
authors noted significantly increased odds ratios (OR) for 
all analyzed complications, with MIs [OR: 56.63; 95% 
confidence interval (CI): 18.04–155.44; P<0.001] and stroke 
(OR: 41.38; 95% CI: 1.98–275.82; P=0.03) presenting the 
greatest risk. As higher BMI individuals already experience 
increased probabilities for complications with unilateral 
TKA compared to non-obese patients, providers may 
want to consider the prospect of sd-BTKA to mitigate the 
cumulative risk staged BTKA bestows upon these patients. 
Conclusions
The United States continues to experience an increase in 
obesity, and arthroplasty surgeons will be faced with the 
decision of operating on these patients. The present study 
determined that high BMI patients undergo meticulous 
selection for sd-BTKA, as evidenced by decreasing age and 
ACCI. However, these patients are still experiencing longer 
LOS, heightened chances for discharge to nursing facilities, 
and increased complication rates compared to their non-
obese counterparts. Despite these differences, obese and 
morbidly patients may be optimized to a level where they 
experience similar risk to those with comparable BMIs 
undergoing unilateral TKA. More research is necessary to 
understand the risk patients accrue when undergoing sd-
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